Skip to main content
Article
Rare Complication of a Commonly Used Antihypertensive Agent: A Case of Hydralazine-Induced ANCA-Associated Vasculitis Presenting as Rapidly Progressive Glomerulonephritis
Internal Medicine
  • Kayle M Warren, HCA Healthcare
  • Khiem T Vu, HCA Healthcare
  • Karandeep Shergill, HCA Healthcare
  • Brian Watson, HCA Healthcare
  • Mohamed Faris, HCA Healthcare
Division
South Atlantic
Hospital
Grand Strand Medical Center
Document Type
Case Report
Publication Date
2-7-2022
Keywords
  • drug‐induced vasculitis,
  • hydralazine,
  • pulmonary hemorrhage,
  • pulmonary‐renal syndrome,
  • rapidly progressive glomerulonephritis
Abstract

Hydralazine-induced ANCA-associated vasculitis is a rare clinical entity, with complications including rapidly progressive glomerulonephritis, pulmonary hemorrhage, and pulmonary-renal syndrome. We present this case to highlight the clinical features that support this challenging diagnosis and to emphasize the importance of prompt recognition and aggressive intervention given its significant morbidity and mortality.

Publisher or Conference
Clinical Case Reports
Citation Information
Warren K, Vu K, Shergill K, Watson B, Faris M. Rare complication of a commonly used antihypertensive agent: A case of hydralazine-induced ANCA-associated vasculitis presenting as rapidly progressive glomerulonephritis. Clin Case Rep. 2022;10(2):e05411. Published 2022 Feb 7. doi:10.1002/ccr3.5411